Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of the Efficacy and Safety of Diclofenac HPBCD 25, 50 mg/ml in the Treatment of Post-surgical Pain Following Dental Surgery

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Patients undergoing surgical extraction of a single fully or partially impacted mandibular 3rd molar requiring bone removal.~* Patients experiencing moderate to severe post-operative pain within 6 hours from end of surgery.~* Pre-operative laboratory tests in the reference ranges or without clinically significant abnormalities as judged by the Investigator.~Exclusion Criteria:~* Surgery performed under general anaesthesia, or sedation.~* Complications occurring during the surgical procedure or in the period before randomisation as judged by the investigator.~* Acute local or systemic infection at the time of surgery that could confound the post-surgical evaluation.~* Patients with clinical signs of gastritis, gastro-duodenal ulcer, GI bleeding. Other GI disturbances or disease that in the opinion of the investigator could be negatively affected by the administration of NSAIDs.~* Clinical signs or history of coagulation disorders that could be negatively affected by NSAIDs administration.~* Hepatic or renal impairment.~* Patients with significant cardiac impairment, history of cerebrovascular disease, history or peripheral arterial disease, uncontrolled hypertension.~* Hypersensitivity to diclofenac or other NSAIDs or to one of the study medication components.~* Patients under chronic treatment with topical or systemic analgesics/NSAIDs.~* Patients under treatment with any medication that may affect the treatment efficacy evaluation.~* Patients under treatment with any medication whose concomitant use may be susceptible to interactions with diclofenac or may affect safety.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Diclofenac HPBCD s.c. 25mg/ml (Type: EXPERIMENTAL): None
- Diclofenac HPBCD s.c. 50mg/ml (Type: EXPERIMENTAL): None
- Diclofenac HPBCD s.c. 75mg/ml (Type: ACTIVE_COMPARATOR): None
- Placebo s.c. (1ml) (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).